DocDollars

Servier Pharmaceuticals LLC

MA · United States · Reporting entity ID 100000246816

Total reported 2019–2025
$125.1M
#79 of 2,960 reporting companies — 0.2% of all reported industry payments
$6.56M in general payments across 21,450 records, plus $118.5M in research funding across 1,067 records.

How it breaks down

General payments $6,558,877
Research funding $118,540,434

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Servier Pharmaceuticals LLC reported $125.1M to US doctors and teaching hospitals from 2019 to 2025, ranking #79 of 2,960 reporting companies. 95% of that was research funding and 5% general payments such as consulting, speaking, food and travel. 21,450 general payment records and 1,067 research records were filed.

Common questions about Servier Pharmaceuticals LLC

How much has Servier Pharmaceuticals LLC paid US doctors?

Servier Pharmaceuticals LLC reported $125,099,311 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $6,558,877 in general payments, $118,540,434 in research funding.

How does Servier Pharmaceuticals LLC rank among drug and device companies?

It ranks #79 of 2,960 reporting entities by total reported value, about 0.2% of all industry payments in the dataset.

Does a payment from Servier Pharmaceuticals LLC mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.